Eli Lilly revs up immunology engine as Olumiant cruises toward coveted alopecia green light
Eli Lilly revs up immunology engine as Olumiant cruises toward [...]
Eli Lilly revs up immunology engine as Olumiant cruises toward [...]
NIH in talks with Pfizer to study a longer course [...]
‘Pharma bro’ Shkreli no longer behind bars—but his lifetime industry [...]
Moderna chairman Afeyan defends hiring practices after CFO debacle: report [...]
Novartis faces Greek bribery lawsuit as government prepares to seek [...]
Valneva’s COVID-19 vaccine faces uncertain future after Europe cancels supply [...]
Buffett’s Berkshire backs out of AbbVie, Bristol Myers Squibb holdings [...]
Emergent boosts countermeasures repertoire with $325M deal for smallpox newcomer [...]
GlaxoSmithKline is no more: Meet the scaled down ‘GSK’ badams [...]
RDT inks deals to push oral film tech to COVID-19 [...]